TuisVEEV • NYSE
add
Veeva Systems Inc
Vorige sluiting
$227,71
Dagwisseling
$224,65 - $228,04
Jaarwisseling
$170,25 - $258,93
Markkapitalisasie
37,02 mjd USD
Gemiddelde volume
1,27 m
P/V-verhouding
52,65
Dividend-opbrengs
-
Primêre beurs
NYSE
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Jan. 2025info | J/J-verandering |
---|---|---|
Inkomste | 720,89 m | 14,31% |
Bedryfskoste | 351,47 m | 9,35% |
Netto inkomste | 195,62 m | 32,72% |
Netto winsgrens | 27,14 | 16,13% |
Wins per aandeel | 1,74 | 26,09% |
EBITDA | 198,36 m | 37,85% |
Effektiewe belastingkoers | 20,20% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Jan. 2025info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 5,15 mjd | 27,87% |
Totale bates | 7,34 mjd | 24,17% |
Totale aanspreeklikheid | 1,51 mjd | 19,06% |
Totale ekwiteit | 5,83 mjd | — |
Uitstaande aandele | 162,70 m | — |
Prys om te bespreek | 6,35 | — |
Opbrengs op bates | 6,83% | — |
Opbrengs op kapitaal | 8,21% | — |
Kontantvloei
Netto kontantverandering
(USD) | Jan. 2025info | J/J-verandering |
---|---|---|
Netto inkomste | 195,62 m | 32,72% |
Kontant van bedrywe | 69,54 m | 20,38% |
Kontant van beleggings | -15,69 m | 81,90% |
Kontant van finansiering | 20,81 m | 298,50% |
Netto kontantverandering | 74,27 m | 284,65% |
Beskikbare kontantvloei | 8,39 m | -54,94% |
Meer oor
Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. Headquartered in Pleasanton, California, it was founded in 2007 by Peter Gassner and Matt Wallach. It operates with software as a service in the life-science industry.
Veeva Systems Inc. went public on the New York Stock Exchange in October 2013. As of May 5, 2022, it has a market capitalization of US$27.5 billion.
On February 1, 2021, Veeva became a public benefit corporation. This made it the first publicly-traded company to convert to a public benefit corporation.
On December 1, 2022, Veeva announced it would not renew its Salesforce partnership when it expired in September 2025, choosing instead to migrate Veeva CRM onto its own Vault Platform. The decision ended a 15+ year collaboration that had given Veeva approximately 80% market share in the life sciences CRM space. Wikipedia
Gestig
2007
Webwerf
Werknemers
7 291